CD86 and neoplasm: After NK-LNP(PA/pDNA) treatment, M1 macrophage polarization markers associated with antitumor immunity (iNOS and CD86) were increased, while M2 macrophage markers associated with tumor progression (CD163 and CD206) were decreased compared to M0 macrophages (Figure 4A) [34].